| Q36270578 | A puromycin selectable cell line for the enrichment of mouse embryonic stem cell-derived V3 interneurons |
| Q40230492 | Active and poised promoter states drive folding of the extended HoxB locus in mouse embryonic stem cells. |
| Q33240362 | Activity of a novel PDGF beta-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma |
| Q35648117 | Cell therapy for multiple sclerosis |
| Q24563638 | Chromatin decondensation and nuclear reorganization of the HoxB locus upon induction of transcription |
| Q38321960 | De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications |
| Q33974841 | Defined conditions for neural commitment and differentiation |
| Q24669858 | Deiodinases: implications of the local control of thyroid hormone action |
| Q57462183 | Derivation of specific neural populations from pluripotent cells for understanding and treatment of spinal cord injury |
| Q39900486 | Differences in the epigenetic and reprogramming properties of pluripotent and extra-embryonic stem cells implicate chromatin remodelling as an important early event in the developing mouse embryo |
| Q35146803 | Differentiation of embryonic stem cells into oligodendrocyte precursors |
| Q37460841 | Differentiation of human oligodendrocytes from pluripotent stem cells |
| Q40556886 | Dividing Olig2-expressing progenitor cells derived from ES cells |
| Q40670067 | Double lox targeting for neural cell transgenesis |
| Q36635953 | Efficient serum-free derivation of oligodendrocyte precursors from neural stem cell-enriched cultures |
| Q38186029 | Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies |
| Q38707941 | Flipping between Polycomb repressed and active transcriptional states introduces noise in gene expression |
| Q37024896 | From stem cells to oligodendrocytes: prospects for brain therapy |
| Q37582826 | Generation and characterization of spiking and nonspiking oligodendroglial progenitor cells from embryonic stem cells |
| Q37344624 | High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology. |
| Q36368251 | Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury |
| Q36498790 | Human embryonic stem cells: preclinical perspectives |
| Q43139724 | Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects |
| Q34161356 | Impact of induced pluripotent stem cells on the study of central nervous system disease |
| Q43093524 | Implication of type 3 deiodinase induction in zebrafish fin regeneration. |
| Q36426340 | In vitro induction of neural differentiation of embryonic stem (ES) cells closely mimics molecular mechanisms of embryonic brain development |
| Q41903175 | Induced neural stem cells generated from rat fibroblasts |
| Q39520271 | Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells |
| Q37982705 | Intracerebral transplantation for neurological disorders. Lessons from developmental, experimental, and clinical studies. |
| Q46826422 | Is REST required for ESC pluripotency? |
| Q43078740 | KRAB zinc-finger proteins localise to novel KAP1-containing foci that are adjacent to PML nuclear bodies. |
| Q36594202 | Methylation of RNA polymerase II non-consensus Lysine residues marks early transcription in mammalian cells |
| Q39858934 | MiR-3099 is Overexpressed in Differentiating 46c Mouse Embryonic Stem Cells upon Neural Induction |
| Q33798722 | Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases |
| Q42587777 | Naive-like conversion overcomes the limited differentiation capacity of induced pluripotent stem cells |
| Q50917302 | Neural stem cells, neurons, and glia. |
| Q36503816 | Neural subtype specification from embryonic stem cells |
| Q24812526 | Niche-independent symmetrical self-renewal of a mammalian tissue stem cell |
| Q46839406 | Notch, epidermal growth factor receptor, and beta1-integrin pathways are coordinated in neural stem cells |
| Q36158033 | Oligodendrocyte progenitor cells derived from mouse embryonic stem cells give rise to type-1 and type-2 astrocytes in vitro |
| Q47129278 | Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination |
| Q43079143 | REST selectively represses a subset of RE1-containing neuronal genes in mouse embryonic stem cells |
| Q41956595 | Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells |
| Q52111898 | Signposts on the neural path. |
| Q35501624 | Specification of neuronal and glial subtypes from human pluripotent stem cells |
| Q37896560 | Stem cell culture engineering - process scale up and beyond |
| Q37747349 | Stem cells in genetic myelin disorders |
| Q38280485 | The impact of chromatin modifiers on the timing of locus replication in mouse embryonic stem cells |
| Q34608659 | Transplantation of oligodendrocyte precursor cells improves locomotion deficits in rats with spinal cord irradiation injury |
| Q37618171 | Transplanted miR-219-overexpressing oligodendrocyte precursor cells promoted remyelination and improved functional recovery in a chronic demyelinated model. |
| Q33392711 | Ultraconserved elements in the Olig2 promoter |